• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按受体状态划分的母乳喂养与乳腺癌风险——一项系统评价和荟萃分析

Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.

作者信息

Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, Boffetta P, Weiss M

机构信息

Surveillance and Health Services Research, American Cancer Society, Atlanta Institute for Translational Epidemiology and the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York.

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, USA.

出版信息

Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26.

DOI:10.1093/annonc/mdv379
PMID:26504151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4855244/
Abstract

BACKGROUND

Breastfeeding is inversely associated with overall risk of breast cancer. This association may differ in breast cancer subtypes defined by receptor status, as they may reflect different mechanisms of carcinogenesis. We conducted a systematic review and meta-analysis of case-control and prospective cohort studies to investigate the association between breastfeeding and breast cancer by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status.

DESIGN

We searched the PubMed and Scopus databases and bibliographies of pertinent articles to identify relevant articles and used random-effects models to calculate summary odds ratios (ORs) and 95% confidence intervals (CIs).

RESULTS

This meta-analysis represents 27 distinct studies (8 cohort and 19 case-control), with a total of 36 881 breast cancer cases. Among parous women, the risk estimates for the association between ever (versus never) breastfeeding and the breast cancers negative for both ER and PR were similar in three cohort and three case-control studies when results were adjusted for several factors, including the number of full-term pregnancies (combined OR 0.90; 95% CI 0.82-0.99), with little heterogeneity and no indication of publication bias. In a subset of three adjusted studies that included ER, PR, and HER2 status, ever breastfeeding showed a stronger inverse association with triple-negative breast cancer (OR 0.78; 95% CI 0.66-0.91) among parous women. Overall, cohort studies showed no significant association between breastfeeding and ER+/PR+ or ER+ and/or PR+ breast cancers, although one and two studies (out of four and seven studies, respectively) showed an inverse association.

CONCLUSIONS

This meta-analysis showed a protective effect of ever breastfeeding against hormone receptor-negative breast cancers, which are more common in younger women and generally have a poorer prognosis than other subtypes of breast cancer. The association between breastfeeding and receptor-positive breast cancers needs more investigation.

摘要

背景

母乳喂养与乳腺癌总体风险呈负相关。这种关联在由受体状态定义的乳腺癌亚型中可能有所不同,因为它们可能反映了不同的致癌机制。我们对病例对照研究和前瞻性队列研究进行了系统评价和荟萃分析,以研究母乳喂养与雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)状态的乳腺癌之间的关联。

设计

我们检索了PubMed和Scopus数据库以及相关文章的参考文献以识别相关文章,并使用随机效应模型计算汇总比值比(OR)和95%置信区间(CI)。

结果

这项荟萃分析涵盖27项不同的研究(8项队列研究和19项病例对照研究),共有36881例乳腺癌病例。在经产妇中,三项队列研究和三项病例对照研究在对包括足月妊娠次数等几个因素进行调整后,曾经(与从未)母乳喂养与ER和PR均为阴性的乳腺癌之间关联的风险估计相似(合并OR 0.90;95%CI 0.82 - 0.99),异质性很小且无发表偏倚迹象。在包括ER、PR和HER2状态的三项调整研究子集中,经产妇中曾经母乳喂养与三阴性乳腺癌的负相关更强(OR 0.78;95%CI 0.66 - 0.91)。总体而言,队列研究显示母乳喂养与ER+/PR+或ER+和/或PR+乳腺癌之间无显著关联,尽管分别有四项研究中的一项和七项研究中的两项显示出负相关。

结论

这项荟萃分析表明曾经母乳喂养对激素受体阴性乳腺癌具有保护作用,这类乳腺癌在年轻女性中更常见,且总体预后比其他亚型乳腺癌更差。母乳喂养与受体阳性乳腺癌之间的关联需要更多研究。

相似文献

1
Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.按受体状态划分的母乳喂养与乳腺癌风险——一项系统评价和荟萃分析
Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26.
2
The Association between ER, PR, HER2, and ER-/PR+ Expression and Lung Cancer Subsequent in Breast Cancer Patients: A Retrospective Cohort Study Based on SEER Database.基于 SEER 数据库的回顾性队列研究:乳腺癌患者中 ER、PR、HER2 和 ER-/PR+ 表达与肺癌后续发生的相关性。
Breast J. 2023 Nov 11;2023:7028189. doi: 10.1155/2023/7028189. eCollection 2023.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.用于子宫肌瘤的选择性孕激素受体调节剂(SPRMs)
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2.
8
Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed.对于无法完全进行母乳喂养的新生儿,奶瓶喂养与其他形式的补充肠内喂养的比较。
Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD005092. doi: 10.1002/14651858.CD005092.pub3.
9
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
10
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.

引用本文的文献

1
Current trends in breast cancer genetics, risk factors, and screening strategies.乳腺癌遗传学、风险因素及筛查策略的当前趋势
J Biol Methods. 2025 Mar 13;12(2):e99010054. doi: 10.14440/jbm.2025.0079. eCollection 2025.
2
Impact of timing and breastfeeding on postpartum breast cancer diagnostic patterns and outcomes.哺乳时间及母乳喂养对产后乳腺癌诊断模式和预后的影响。
Breast Cancer Res Treat. 2025 Nov;214(1):79-86. doi: 10.1007/s10549-025-07796-2. Epub 2025 Jul 30.
3
Co-creating and Mapping an Exclusive Breastfeeding Framework among Latino Populations in the United States: An Integrated Framework Adaptation Process and Scoping Review.在美国拉丁裔人群中共同创建和绘制独家母乳喂养框架:一个综合框架适应过程和范围审查。
Adv Nutr. 2025 Jul 19;16(9):100483. doi: 10.1016/j.advnut.2025.100483.
4
Differential ER stress responses during lactation and postpartum outcomes in mice depending on their mitochondrial genotype.小鼠哺乳期不同的内质网应激反应及其产后结局取决于它们的线粒体基因型。
Nat Commun. 2025 Jul 11;16(1):6432. doi: 10.1038/s41467-025-61666-5.
5
BREAST CANCER AND PROLACTIN: A LIFETIME RELATIONSHIP.乳腺癌与催乳素:一生的关联。
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):349-355. doi: 10.4183/aeb.2024.349. Epub 2025 May 23.
6
Breastfeeding attributable fraction of triple negative breast cancer in the US.美国三阴性乳腺癌的母乳喂养归因分数
NPJ Breast Cancer. 2025 May 7;11(1):40. doi: 10.1038/s41523-025-00755-6.
7
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.具有BRCA1致病变异的女性的生育次数、母乳喂养与早发性乳腺癌风险
Br J Cancer. 2025 May 2. doi: 10.1038/s41416-025-03029-x.
8
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.19个队列中绝经前乳腺癌风险预测模型的开发与验证
Breast Cancer Res. 2025 May 1;27(1):67. doi: 10.1186/s13058-025-02031-8.
9
Breastfeeding and Maternal and Child Cardiometabolic Outcomes 10-14 Years after Delivery.分娩后10至14年的母乳喂养与母婴心脏代谢结局
Breastfeed Med. 2025 Jun;20(6):402-408. doi: 10.1089/bfm.2024.0397. Epub 2025 Mar 11.
10
Identifying Factors Associated With Breastfeeding Length Among Filipino Migrant Women in South Korea.识别韩国菲律宾移民女性母乳喂养时长的相关因素。
J Hum Nutr Diet. 2025 Apr;38(2):e70030. doi: 10.1111/jhn.70030.

本文引用的文献

1
Mammographic density and breast cancer in women from high risk families.高危家族女性的乳腺X线密度与乳腺癌
Breast Cancer Res. 2015 Jul 11;17(1):93. doi: 10.1186/s13058-015-0604-1.
2
Influence of factors on mammographic density in premenopausal Chinese women.因素对中国绝经前女性乳腺X线密度的影响。
Eur J Cancer Prev. 2016 Jul;25(4):306-11. doi: 10.1097/CEJ.0000000000000177.
3
Mammographic density and breast cancer risk by family history in women of white and Asian ancestry.白种人和亚洲血统女性的乳腺X线密度及家族史与乳腺癌风险
Cancer Causes Control. 2015 Apr;26(4):621-6. doi: 10.1007/s10552-015-0551-2. Epub 2015 Mar 12.
4
The contributions of breast density and common genetic variation to breast cancer risk.乳腺密度和常见基因变异对乳腺癌风险的影响。
J Natl Cancer Inst. 2015 Mar 4;107(5). doi: 10.1093/jnci/dju397. Print 2015 May.
5
Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.非裔美国女性的生育次数、哺乳情况与乳腺癌亚型:AMBER联盟的研究结果
J Natl Cancer Inst. 2014 Sep 15;106(10). doi: 10.1093/jnci/dju237. Print 2014 Oct.
6
Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?年轻女性乳腺癌:乳腺癌亚型的预后意义是否随时间发生了变化?
Breast Cancer Res Treat. 2014 Oct;147(3):617-29. doi: 10.1007/s10549-014-3125-1. Epub 2014 Sep 11.
7
Adherence to breastfeeding guidelines and maternal weight 6 years after delivery.产后6年对母乳喂养指南的遵循情况及产妇体重
Pediatrics. 2014 Sep;134 Suppl 1(0 1):S42-9. doi: 10.1542/peds.2014-0646H.
8
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.BRCA1 和 BRCA2 突变携带者癌症风险的修饰因素:系统评价和荟萃分析。
J Natl Cancer Inst. 2014 Jun;106(6):dju091. doi: 10.1093/jnci/dju091.
9
Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.挪威女性前瞻性研究中的生殖史与分子乳腺癌亚型风险
Cancer Causes Control. 2014 Jul;25(7):881-9. doi: 10.1007/s10552-014-0388-0. Epub 2014 May 1.
10
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.美国联合激素受体和 HER2 状态定义的乳腺癌亚型发病率。
J Natl Cancer Inst. 2014 Apr 28;106(5):dju055. doi: 10.1093/jnci/dju055.